Alina Diana Zamfir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alina Diana Zamfir has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Mirela Sarbu
National Institute for Research and Development in Electrochemistry and Condensed Matter
22 shared publicationsŽeljka Vukelić
University of Zagreb
18 shared publicationsCorina Flangea
Laboratory for the Analysis and Modeling of Biological Systems, Aurel Vlaicu University of Arad, Blvd. Revolutiei 77, 310130 Arad, Romania
16 shared publications- Eugen Sisu
Department of Biochemistry and Pharmacology, “Victor Babes” University of Medicine and Pharmacy, RO-300041 Timisoara, Romania
15 shared publications - Cristian V. A. Munteanu
Department of Bioinformatics and Structural Biochemistry, Institute of Biochemistry of the Romanian Academy, Bucharest, Romania
12 shared publications - Alina Serb
Department of Biochemistry and Pharmacology, Biochemistry Discipline, “Victor Babes” University of Medicine and Pharmacy Timișoara, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania
11 shared publications
Latest Publications
- 31 October 2026
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
Ion Mobility Mass Spectrometry Enables the Generation of a Ganglioside Atlas in Oligodendroglioma and Matched Peritumoral Tissues
Oligodendroglioma is a diffuse glioma defined by IDH mutation and whole-arm 1p/19q codeletion. Although gangliosides play essential roles in membrane organization and tumor biology, their molecular diversity in oligodendrogliomas remains poorly understood because of the limited structural resolution of conventional analytical approaches. Gangliosides extracted from paired tumoral and peritumoral tissues from three patients with oligodendroglioma were analyzed using an integrated workflow combining high-performance thin-layer chromatography (HPTLC) and high-resolution cyclic ion mobility mass spectrometry. Molecular annotation included canonical, O-acetylated, and fucosylated ganglioside species. A total of 205 distinct ganglioside molecular species were identified, providing a detailed molecular-species-level characterization of the gangliosidome in the analyzed oligodendroglioma and matched peritumoral tissue. Tumoral tissues contained 184 species, peritumoral tissues contained 171 species, and 148 species were shared, including a set of 55 ganglioside molecular species detected in all samples. Oligodendroglioma retained a diverse inventory of complex GD-, GT-, GQ-, and GP-series gangliosides together with numerous O-acetylated and fucosylated structures. Despite greater molecular diversity in tumors, the overall ganglioside class distribution and ceramide composition remained largely conserved, indicating that the remodeling process predominantly affects glycan head groups rather than the ceramide scaffold. This study provides the first detailed cyclic ion mobility mass spectrometry (cIMS-MS) characterization of the gangliosidome in isocitrate dehydrogenase (IDH) mutant, 1p/19q-codeleted oligodendroglioma. The findings substantially expand the known molecular diversity of this tumor type and identify selective glycan alterations with the preservation of ceramide architecture as a defining molecular feature, providing a framework for future biomarker discovery and mechanistic studies of glycosphingolipid metabolism in diffuse gliomas.
- 31 October 2026
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
Ion Mobility Mass Spectrometry Enables the Generation of a Ganglioside Atlas in Oligodendroglioma and Matched Peritumoral Tissues
Oligodendroglioma is a diffuse glioma defined by IDH mutation and whole-arm 1p/19q codeletion. Although gangliosides play essential roles in membrane organization and tumor biology, their molecular diversity in oligodendrogliomas remains poorly understood because of the limited structural resolution of conventional analytical approaches. Gangliosides extracted from paired tumoral and peritumoral tissues from three patients with oligodendroglioma were analyzed using an integrated workflow combining high-performance thin-layer chromatography (HPTLC) and high-resolution cyclic ion mobility mass spectrometry. Molecular annotation included canonical, O-acetylated, and fucosylated ganglioside species. A total of 205 distinct ganglioside molecular species were identified, providing a detailed molecular-species-level characterization of the gangliosidome in the analyzed oligodendroglioma and matched peritumoral tissue. Tumoral tissues contained 184 species, peritumoral tissues contained 171 species, and 148 species were shared, including a set of 55 ganglioside molecular species detected in all samples. Oligodendroglioma retained a diverse inventory of complex GD-, GT-, GQ-, and GP-series gangliosides together with numerous O-acetylated and fucosylated structures. Despite greater molecular diversity in tumors, the overall ganglioside class distribution and ceramide composition remained largely conserved, indicating that the remodeling process predominantly affects glycan head groups rather than the ceramide scaffold. This study provides the first detailed cyclic ion mobility mass spectrometry (cIMS-MS) characterization of the gangliosidome in isocitrate dehydrogenase (IDH) mutant, 1p/19q-codeleted oligodendroglioma. The findings substantially expand the known molecular diversity of this tumor type and identify selective glycan alterations with the preservation of ceramide architecture as a defining molecular feature, providing a framework for future biomarker discovery and mechanistic studies of glycosphingolipid metabolism in diffuse gliomas.
- Open Access
- 14 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 12029
Overexpression of GM3 and Ganglioside Pattern Remodeling in Lung Adenocarcinoma Brain Metastases Identified by Ion Mobility Mass Spectrometry
Lung adenocarcinoma (LUAD), the most prevalent subtype of non-small cell lung carcinoma (NSCLC), commonly metastasizes to the brain, particularly in advanced stages. Since brain metastases (BMs) are a leading cause of morbidity and mortality in LUAD patients, their early detection is critical, necessitating the identification of reliable biomarkers. Gangliosides (GGs), a class of bioactive glycosphingolipids involved in cell signaling, adhesion, and immune regulation, have emerged as promising candidates for diagnostic and therapeutic targeting in LUAD-associated brain metastases (BMLA). In this context, ion mobility spectrometry mass spectrometry (IMS-MS) was employed here to analyze GG alterations in BMLA tissues compared to healthy cerebellar control. The results revealed marked differences, including a reduction in the total number of species, altered sialylation profiles, and variations in fatty acid chain length and sphingoid base hydroxylation. GM3, a monosialodihexosylganglioside, was significantly overexpressed in BMLA, supporting its role in tumor progression via immune evasion and oncogenic signaling. Elevated levels of the brain-specific GT1 ganglioside further point to its possible role as a metastasis-associated biomarker, while the presence of asialogangliosides, absent in normal brain, suggests adaptation to the brain microenvironment. Structural modifications such as O-acetylation, fucosylation, and CH3COO− were more frequent in BMLA, being associated with aggressive tumor phenotypes. Ceramide profiles revealed increased levels of proliferative C16- and C24-ceramides and decreased pro-apoptotic C18-ceramide. Additionally, GM3(d18:1/22:0) and GD3(d18:1/16:0), identified as potential BMLA biomarkers, were structurally characterized using (−) nanoelectrospray ionization (nanoESI) IMS collision-induced dissociation tandem MS (CID MS/MS). Collectively, these findings highlight the clinical potential of GGs for early diagnosis and targeted therapy in BMLA.
- 14 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 12029
Open AccessOverexpression of GM3 and Ganglioside Pattern Remodeling in Lung Adenocarcinoma Brain Metastases Identified by Ion Mobility Mass Spectrometry
Lung adenocarcinoma (LUAD), the most prevalent subtype of non-small cell lung carcinoma (NSCLC), commonly metastasizes to the brain, particularly in advanced stages. Since brain metastases (BMs) are a leading cause of morbidity and mortality in LUAD patients, their early detection is critical, necessitating the identification of reliable biomarkers. Gangliosides (GGs), a class of bioactive glycosphingolipids involved in cell signaling, adhesion, and immune regulation, have emerged as promising candidates for diagnostic and therapeutic targeting in LUAD-associated brain metastases (BMLA). In this context, ion mobility spectrometry mass spectrometry (IMS-MS) was employed here to analyze GG alterations in BMLA tissues compared to healthy cerebellar control. The results revealed marked differences, including a reduction in the total number of species, altered sialylation profiles, and variations in fatty acid chain length and sphingoid base hydroxylation. GM3, a monosialodihexosylganglioside, was significantly overexpressed in BMLA, supporting its role in tumor progression via immune evasion and oncogenic signaling. Elevated levels of the brain-specific GT1 ganglioside further point to its possible role as a metastasis-associated biomarker, while the presence of asialogangliosides, absent in normal brain, suggests adaptation to the brain microenvironment. Structural modifications such as O-acetylation, fucosylation, and CH3COO− were more frequent in BMLA, being associated with aggressive tumor phenotypes. Ceramide profiles revealed increased levels of proliferative C16- and C24-ceramides and decreased pro-apoptotic C18-ceramide. Additionally, GM3(d18:1/22:0) and GD3(d18:1/16:0), identified as potential BMLA biomarkers, were structurally characterized using (−) nanoelectrospray ionization (nanoESI) IMS collision-induced dissociation tandem MS (CID MS/MS). Collectively, these findings highlight the clinical potential of GGs for early diagnosis and targeted therapy in BMLA.
- Open Access
- 6 December 2025
- Published by Springer Nature in Communications Chemistry
- Vol. 8 (1)
Deficiency of Toll-like receptor 2 is a driver of sex-related compositional and structural rearrangements of membrane lipids
The behavior and function of membrane microdomains is shaped by the intricate liaison between the most complex glycosphingolipids-gangliosides, cholesterol and specific classes of transmembrane proteins. Toll-like receptor 2 (TLR2), a pattern recognition receptor localized in lipid rafts, is implicated in different membrane-associated events, some of which overlap between gangliosides and TLR2, such as pathogen recognition and neuroinflammation. Aiming to determine whether TLR2 deficiency influences on the composition and arrangement of membrane lipids, we examined cortical tissue of TLR2-deficient and control mice by in-depth glycolipidomic profiling along with transcriptomic analysis of genes involved in ganglioside and cholesterol metabolism. A multi-level experimental approach, including powerful high-resolution mass spectrometry techniques, provided a detailed lipidomic data and elaborate structural characterization of brain gangliosidome and sterolome in TLR2 deficiency. The results demonstrate the presence of distinct brain glycolipidomic and sterol pattern as well as lipid redistribution within the membrane fractions in TLR2 deficiency. In addition, the findings speak in favor of a sex-specific structural and functional partnership of TLR2, gangliosides and cholesterol in the brain tissue that may act as a connection point integrating extracellular stimuli and modulating neuroimmune response in a sex-dependent manner.
- 6 December 2025
- Published by Springer Nature in Communications Chemistry
- Vol. 8 (1)
Open AccessDeficiency of Toll-like receptor 2 is a driver of sex-related compositional and structural rearrangements of membrane lipids
The behavior and function of membrane microdomains is shaped by the intricate liaison between the most complex glycosphingolipids-gangliosides, cholesterol and specific classes of transmembrane proteins. Toll-like receptor 2 (TLR2), a pattern recognition receptor localized in lipid rafts, is implicated in different membrane-associated events, some of which overlap between gangliosides and TLR2, such as pathogen recognition and neuroinflammation. Aiming to determine whether TLR2 deficiency influences on the composition and arrangement of membrane lipids, we examined cortical tissue of TLR2-deficient and control mice by in-depth glycolipidomic profiling along with transcriptomic analysis of genes involved in ganglioside and cholesterol metabolism. A multi-level experimental approach, including powerful high-resolution mass spectrometry techniques, provided a detailed lipidomic data and elaborate structural characterization of brain gangliosidome and sterolome in TLR2 deficiency. The results demonstrate the presence of distinct brain glycolipidomic and sterol pattern as well as lipid redistribution within the membrane fractions in TLR2 deficiency. In addition, the findings speak in favor of a sex-specific structural and functional partnership of TLR2, gangliosides and cholesterol in the brain tissue that may act as a connection point integrating extracellular stimuli and modulating neuroimmune response in a sex-dependent manner.
- Open Access
- 22 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2854
Glycosphingolipids in Dementia: Insights from Mass Spectrometry and Systems Biology Approaches
This narrative literature review synthesizes recent evidence on glycosphingolipid (GSL) dysregulation in dementia, emphasizing discoveries enabled by mass spectrometry (MS) and systems biology. Focusing on the research published within the last decade, we selected studies that are relevant to GSL alterations in dementia and notable for their methodological advances. The findings were conceptually integrated to emphasize key molecular, analytical, and systems-level aspects across the major dementia types. The results from MS-based glycolipidomics in Alzheimer’s disease, dementia with Lewy bodies, frontotemporal dementia, Parkinson’s disease dementia, and Huntington’s disease consistently indicate altered GSL metabolism and shared molecular vulnerabilities in neuronal lipid regulation. At the same time, distinct GSL signatures differentiate individual dementias, reflecting the disease-specific mechanisms of neurodegeneration. The literature also reveals that recent advances in high-resolution MS and integrative analytical workflows have shifted GSL research from descriptive to mechanistic, facilitating the detailed mapping of species linked to neuroinflammation, protein aggregation, and synaptic dysfunction. Systems-level analyses combining MS data with other omics approaches increasingly depict GSLs as active regulators of neuronal function rather than inert membrane components. At the same time, emerging trends position GSLs as promising early biomarkers and potential therapeutic targets, while the growing use of artificial intelligence in MS data analysis is accelerating the detection of their subtle patterns, improving cross-disease comparisons. Together, these results reinforce the major role of MS-based platforms in discovering dementia-associated GSLs, identifying therapeutic targets, and influencing future strategies for diagnosis and treatment.
- 22 November 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (12) , 2854
Open AccessGlycosphingolipids in Dementia: Insights from Mass Spectrometry and Systems Biology Approaches
This narrative literature review synthesizes recent evidence on glycosphingolipid (GSL) dysregulation in dementia, emphasizing discoveries enabled by mass spectrometry (MS) and systems biology. Focusing on the research published within the last decade, we selected studies that are relevant to GSL alterations in dementia and notable for their methodological advances. The findings were conceptually integrated to emphasize key molecular, analytical, and systems-level aspects across the major dementia types. The results from MS-based glycolipidomics in Alzheimer’s disease, dementia with Lewy bodies, frontotemporal dementia, Parkinson’s disease dementia, and Huntington’s disease consistently indicate altered GSL metabolism and shared molecular vulnerabilities in neuronal lipid regulation. At the same time, distinct GSL signatures differentiate individual dementias, reflecting the disease-specific mechanisms of neurodegeneration. The literature also reveals that recent advances in high-resolution MS and integrative analytical workflows have shifted GSL research from descriptive to mechanistic, facilitating the detailed mapping of species linked to neuroinflammation, protein aggregation, and synaptic dysfunction. Systems-level analyses combining MS data with other omics approaches increasingly depict GSLs as active regulators of neuronal function rather than inert membrane components. At the same time, emerging trends position GSLs as promising early biomarkers and potential therapeutic targets, while the growing use of artificial intelligence in MS data analysis is accelerating the detection of their subtle patterns, improving cross-disease comparisons. Together, these results reinforce the major role of MS-based platforms in discovering dementia-associated GSLs, identifying therapeutic targets, and influencing future strategies for diagnosis and treatment.
- Open Access
- 15 October 2025
- Published by MDPI AG in Preprints.org
Glycosphingolipids in Dementia: Insights from Mass Spectrometry and Systems Biology Approaches
This review synthesizes the current evidence on glycolipid dysregulation in dementia, with a focus on the data generated by mass spectrometry (MS) and systems biology approaches. Glycolipids, key regulators of neuronal function and integrity, have emerged as important players in neurodegenerative processes. In this context, we ex-amine here their altered expression reported in major forms of dementia, including Alzheimer’s disease, frontotemporal dementia, dementia with Lewy body, Parkinson's disease dementia, Huntington’s disease, and mixed dementia. By comparing these conditions, we identified molecular signatures that appear broadly conserved, suggesting common pathways of neuronal vulnerability, while also outlining disease-specific changes that may cause the observed clinical diversity. A special consideration is given to methodological advances, particularly the development and application of high performance MS in glyolipidomics and integrative analytical workflows, which have significantly expanded our understanding of lipid-mediated mechanisms in the diseased brain. Situating these findings within the context of dementia research, we further discuss here how glycolipid biology intersects with protein aggregation, neuroinflammation, and synaptic dysfunction. The results assessed here highlight the major role of MS-based platforms in discovery of glycolipids associated to dementia pathogenesis and at the same time of species with potential biomarker role and/or as novel targets for therapeutic intervention. This review, thus, provides an integrative perspective on glycolipid research by modern MS and allied techniques, emphasizing its potential to influence future strategies for diagnosis and treatment of dementia.
- 15 October 2025
- Published by MDPI AG in Preprints.org
Open AccessGlycosphingolipids in Dementia: Insights from Mass Spectrometry and Systems Biology Approaches
This review synthesizes the current evidence on glycolipid dysregulation in dementia, with a focus on the data generated by mass spectrometry (MS) and systems biology approaches. Glycolipids, key regulators of neuronal function and integrity, have emerged as important players in neurodegenerative processes. In this context, we ex-amine here their altered expression reported in major forms of dementia, including Alzheimer’s disease, frontotemporal dementia, dementia with Lewy body, Parkinson's disease dementia, Huntington’s disease, and mixed dementia. By comparing these conditions, we identified molecular signatures that appear broadly conserved, suggesting common pathways of neuronal vulnerability, while also outlining disease-specific changes that may cause the observed clinical diversity. A special consideration is given to methodological advances, particularly the development and application of high performance MS in glyolipidomics and integrative analytical workflows, which have significantly expanded our understanding of lipid-mediated mechanisms in the diseased brain. Situating these findings within the context of dementia research, we further discuss here how glycolipid biology intersects with protein aggregation, neuroinflammation, and synaptic dysfunction. The results assessed here highlight the major role of MS-based platforms in discovery of glycolipids associated to dementia pathogenesis and at the same time of species with potential biomarker role and/or as novel targets for therapeutic intervention. This review, thus, provides an integrative perspective on glycolipid research by modern MS and allied techniques, emphasizing its potential to influence future strategies for diagnosis and treatment of dementia.
- Open Access
- 29 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8433
Novel Application of Ion Mobility Mass Spectrometry Reveals Complex Ganglioside Landscape in Diffuse Astrocytoma Peritumoral Regions
Diffuse astrocytoma is a primary brain tumor known for its gradual and diffuse infiltration into the surrounding brain tissue. Given this characteristic, the investigation of the peritumoral region holds potential biological and clinical relevance. In this study, ion mobility spectrometry mass spectrometry (IMS MS) was optimized and applied for the first time for the analysis of gangliosides present in the peritumoral tissue of diffuse astrocytoma. Ganglioside profiling and structural characterization were conducted using high-resolution nanoelectrospray ionization (nanoESI) IMS MS, along with tandem mass spectrometry (MS/MS) via low-energy collision-induced dissociation (CID) in the negative ion mode. Using IMS MS-based separation and screening, we observed a greater diversity of ganglioside species in the peritumoral tissue than previously reported. Notably, an elevated expression was detected for several species, including GT1(d18:1/18:0), GT1(d18:1/20:0), GM2(d18:1/16:2), GD1(d18:1/16:0), GD2(d18:1/20:0), Fuc-GT3(d18:1/24:4), and Fuc-GD1(d18:1/18:2). Although preliminary, these observations prompt consideration of whether these species could be implicated in processes such as microenvironmental modulation, tumor cell infiltration and invasion, maintenance of cellular interactions, or regulation of immune responses. Additionally, their potential utility as biomarkers may merit further exploration. In the subsequent phase of the study, structural analysis using IMS MS, CID tandem MS, and fragmentation data supported the identification of GT1b(d18:1/20:0) isomer in the peritumoral tissue. However, given the exploratory nature of the study and reliance on limited sampling, further investigation across broader sample sets is necessary to extend these findings.
- 29 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8433
Open AccessNovel Application of Ion Mobility Mass Spectrometry Reveals Complex Ganglioside Landscape in Diffuse Astrocytoma Peritumoral Regions
Diffuse astrocytoma is a primary brain tumor known for its gradual and diffuse infiltration into the surrounding brain tissue. Given this characteristic, the investigation of the peritumoral region holds potential biological and clinical relevance. In this study, ion mobility spectrometry mass spectrometry (IMS MS) was optimized and applied for the first time for the analysis of gangliosides present in the peritumoral tissue of diffuse astrocytoma. Ganglioside profiling and structural characterization were conducted using high-resolution nanoelectrospray ionization (nanoESI) IMS MS, along with tandem mass spectrometry (MS/MS) via low-energy collision-induced dissociation (CID) in the negative ion mode. Using IMS MS-based separation and screening, we observed a greater diversity of ganglioside species in the peritumoral tissue than previously reported. Notably, an elevated expression was detected for several species, including GT1(d18:1/18:0), GT1(d18:1/20:0), GM2(d18:1/16:2), GD1(d18:1/16:0), GD2(d18:1/20:0), Fuc-GT3(d18:1/24:4), and Fuc-GD1(d18:1/18:2). Although preliminary, these observations prompt consideration of whether these species could be implicated in processes such as microenvironmental modulation, tumor cell infiltration and invasion, maintenance of cellular interactions, or regulation of immune responses. Additionally, their potential utility as biomarkers may merit further exploration. In the subsequent phase of the study, structural analysis using IMS MS, CID tandem MS, and fragmentation data supported the identification of GT1b(d18:1/20:0) isomer in the peritumoral tissue. However, given the exploratory nature of the study and reliance on limited sampling, further investigation across broader sample sets is necessary to extend these findings.
- Open Access
- 14 July 2025
- Published by Springer Nature in Research Square
Overexpression of GM3 and Ganglioside Pattern Remodeling in Lung Adenocarcinoma Brain Metastases Identified by Ion Mobility Mass Spectrometry
Lung adenocarcinoma (LUAD), the most prevalent subtype of non-small cell lung carcinoma commonly metastasizes to the brain, worsening patient prognosis. Early detection of brain metastases (BMs) is therefore critical, highlighting the need for reliable biomarkers. Gangliosides (GGs)—bioactive glycosphingolipids involved in cellular signaling and immune responses—have emerged as promising candidates. In this context, ion mobility separation mass spectrometry (IMS MS) was used here to analyze GG alterations in LUAD-associated brain metastases (BMLA) compared to healthy cerebellar tissue. The results revealed a reduced diversity of GG species, altered sialylation, and differences in fatty acid and sphingoid base structures. GM3 was overexpressed in BMLA, supporting its role in tumor progression via immune evasion and oncogenic signaling. Brain-specific GT1 and unusual asialogangliosides—absent in normal brain—were also elevated, suggesting their relevance in metastasis and brain adaptation. Structural modifications such as O-acetylation and fucosylation, were more frequent in BMLA, being linked to aggressive tumor traits. Ceramide profiles revealed increased levels of proliferative C16- and C24-ceramides and decreased pro-apoptotic C18-ceramide. Additionally, GD3(d18:1/16:0), identified as a potential BMLA biomarker, was structurally characterized using (–) nanoESI IMS CID MS/MS. These findings underscore the diagnostic and therapeutic promise of GG profiling in LUAD brain metastases.
- 14 July 2025
- Published by Springer Nature in Research Square
Open AccessOverexpression of GM3 and Ganglioside Pattern Remodeling in Lung Adenocarcinoma Brain Metastases Identified by Ion Mobility Mass Spectrometry
Lung adenocarcinoma (LUAD), the most prevalent subtype of non-small cell lung carcinoma commonly metastasizes to the brain, worsening patient prognosis. Early detection of brain metastases (BMs) is therefore critical, highlighting the need for reliable biomarkers. Gangliosides (GGs)—bioactive glycosphingolipids involved in cellular signaling and immune responses—have emerged as promising candidates. In this context, ion mobility separation mass spectrometry (IMS MS) was used here to analyze GG alterations in LUAD-associated brain metastases (BMLA) compared to healthy cerebellar tissue. The results revealed a reduced diversity of GG species, altered sialylation, and differences in fatty acid and sphingoid base structures. GM3 was overexpressed in BMLA, supporting its role in tumor progression via immune evasion and oncogenic signaling. Brain-specific GT1 and unusual asialogangliosides—absent in normal brain—were also elevated, suggesting their relevance in metastasis and brain adaptation. Structural modifications such as O-acetylation and fucosylation, were more frequent in BMLA, being linked to aggressive tumor traits. Ceramide profiles revealed increased levels of proliferative C16- and C24-ceramides and decreased pro-apoptotic C18-ceramide. Additionally, GD3(d18:1/16:0), identified as a potential BMLA biomarker, was structurally characterized using (–) nanoESI IMS CID MS/MS. These findings underscore the diagnostic and therapeutic promise of GG profiling in LUAD brain metastases.
- Open Access
- 30 June 2025
- Published by MDPI AG in Preprints.org
Novel Application of Ion Mobility Mass Spectrometry Reveals Complex Ganglioside Landscape in Diffuse Astrocytoma Peritumoral Regions
Diffuse astrocytoma is a primary brain tumor characterized by an insidious infiltration of tumor cells into surrounding brain tissue. Considering this trait, investigation of the peritumoral region is of major biological and clinical importance. In this study, ion mobility mass spectrometry (IMS MS) was optimized and introduced for the first time in the analysis of gangliosides expressed in the peritumoral tissue of diffuse astrocytoma. Profiling and structural analysis of ganglioside species were performed by high-resolution nanoelectrospray ionization (nanoESI) IMS MS and tandem MS (MS/MS) by collision induced dissociation at low energies tuned in the negative ion mode. Through IMS MS separation and screening, we discovered that the diversity of gangliosides in peritumoral tissue is significantly larger than previously reported. We observed the high expression of GT1(d18:1/18:0), GT1(d18:1/20:0), GM2(d18:1/16:2), GD1(d18:1/16:0), GD2(d18:1/20:0), Fuc-GT3(d18:1/24:4), and Fuc-GD1(d18:1/18:2), which suggest that these species: a) are potential biomarkers; b) create a microenvironment favorable to the infiltration of the tumor cells; c) promote the invasion of diffuse astrocytoma cells; d) uphold cellular interactions and possibly influence immune responses.In the second phase, IMS MS, tandem MS, and fragmentation data confirmed the structure of GT1(d18:1/20:0), identifying GT1b as the only isomer present in peritumoral regions.
- 30 June 2025
- Published by MDPI AG in Preprints.org
Open AccessNovel Application of Ion Mobility Mass Spectrometry Reveals Complex Ganglioside Landscape in Diffuse Astrocytoma Peritumoral Regions
Diffuse astrocytoma is a primary brain tumor characterized by an insidious infiltration of tumor cells into surrounding brain tissue. Considering this trait, investigation of the peritumoral region is of major biological and clinical importance. In this study, ion mobility mass spectrometry (IMS MS) was optimized and introduced for the first time in the analysis of gangliosides expressed in the peritumoral tissue of diffuse astrocytoma. Profiling and structural analysis of ganglioside species were performed by high-resolution nanoelectrospray ionization (nanoESI) IMS MS and tandem MS (MS/MS) by collision induced dissociation at low energies tuned in the negative ion mode. Through IMS MS separation and screening, we discovered that the diversity of gangliosides in peritumoral tissue is significantly larger than previously reported. We observed the high expression of GT1(d18:1/18:0), GT1(d18:1/20:0), GM2(d18:1/16:2), GD1(d18:1/16:0), GD2(d18:1/20:0), Fuc-GT3(d18:1/24:4), and Fuc-GD1(d18:1/18:2), which suggest that these species: a) are potential biomarkers; b) create a microenvironment favorable to the infiltration of the tumor cells; c) promote the invasion of diffuse astrocytoma cells; d) uphold cellular interactions and possibly influence immune responses.In the second phase, IMS MS, tandem MS, and fragmentation data confirmed the structure of GT1(d18:1/20:0), identifying GT1b as the only isomer present in peritumoral regions.
- 23 August 2024
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 35 (9) , 2102-2117
Introducing Ion Mobility Mass Spectrometry in Brain Glycosaminoglycomics: Application to Chondroitin/Dermatan Sulfate Octasaccharide Domains
Glycosaminoglycans (GAGs) are sulfated linear O-glycan chains abundantly expressed in the extracellular matrix (ECM). Among GAGs, chondroitin sulfate (CS) and dermatan sulfate (DS) play important roles at the brain level, where the distribution and location of the sulfates within the CS/DS chains are responsible for numerous biological events. The diversity of the neural hybrid CS/DS expressed in the brain and the need to elucidate their structure gave rise to considerable efforts toward the development of analytical methods able to discover novel regularly and irregularly sulfated domains. In this context, we report here the introduction of ion mobility separation (IMS) mass spectrometry (MS) in brain glycosaminoglycomics. Based on IMS MS and tandem MS (MS/MS) by collision-induced dissociation (CID), we have developed a powerful approach for the screening and structural analysis of neural CS/DS and optimized and validated the method for the structural analysis of octasaccharides that were released from brain proteoglycans by β-elimination and pooled after chain depolymerization using chondroitin AC lyase. The IMS MS data revealed the separation of CS/DS octamers into mobility families based on the amount of sulfation. Among the discovered oversulfated domains, of major biological importance is the pentasulfated-[4,5-Δ-GlcAGalNAc(IdoAGalNAc)3], for which the (-) nanoESI IMS CID MS/MS analysis disclosed through the presence of distinct drift times, the incidence of two isomers. Moreover, the generated fragment ions revealed an uncommon trisulfated motif and an uncommon pentasulfated motif. Hence, using IMS MS and CID MS/MS, novel brain-related CS/DS domains of atypical sulfation patterns were discovered and structurally characterized in detail.
- 23 August 2024
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 35 (9) , 2102-2117
Introducing Ion Mobility Mass Spectrometry in Brain Glycosaminoglycomics: Application to Chondroitin/Dermatan Sulfate Octasaccharide Domains
Glycosaminoglycans (GAGs) are sulfated linear O-glycan chains abundantly expressed in the extracellular matrix (ECM). Among GAGs, chondroitin sulfate (CS) and dermatan sulfate (DS) play important roles at the brain level, where the distribution and location of the sulfates within the CS/DS chains are responsible for numerous biological events. The diversity of the neural hybrid CS/DS expressed in the brain and the need to elucidate their structure gave rise to considerable efforts toward the development of analytical methods able to discover novel regularly and irregularly sulfated domains. In this context, we report here the introduction of ion mobility separation (IMS) mass spectrometry (MS) in brain glycosaminoglycomics. Based on IMS MS and tandem MS (MS/MS) by collision-induced dissociation (CID), we have developed a powerful approach for the screening and structural analysis of neural CS/DS and optimized and validated the method for the structural analysis of octasaccharides that were released from brain proteoglycans by β-elimination and pooled after chain depolymerization using chondroitin AC lyase. The IMS MS data revealed the separation of CS/DS octamers into mobility families based on the amount of sulfation. Among the discovered oversulfated domains, of major biological importance is the pentasulfated-[4,5-Δ-GlcAGalNAc(IdoAGalNAc)3], for which the (-) nanoESI IMS CID MS/MS analysis disclosed through the presence of distinct drift times, the incidence of two isomers. Moreover, the generated fragment ions revealed an uncommon trisulfated motif and an uncommon pentasulfated motif. Hence, using IMS MS and CID MS/MS, novel brain-related CS/DS domains of atypical sulfation patterns were discovered and structurally characterized in detail.